New Key Statistics Module, Z-Score and F-Score
NAS:KPRX Key Ratios
| Market Cap $ M | 14.33 |
| Enterprise Value $ M | -16.85 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 1.77 |
| Price/Book | 0.41 |
| Price/Sales | 1.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 7.69 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 16.00 |
| EPS (TTM) $ | -1.59 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 33.90 |
| 5-y EBITDA Growth Rate % | 52.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.72 |
| EV-to-EBITDA | -6.60 |
| PEG | -- |
| Shares Outstanding M | 26.26 |
| Net Margin (%) | 17.54 |
| Operating Margin % | 38.93 |
| Pre-tax Margin (%) | 18.11 |
| Quick Ratio | 21.02 |
| Current Ratio | 21.02 |
| ROA % (ttm) | 12.94 |
| ROE % (ttm) | 19.25 |
| ROIC % (ttm) | 60.74 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.76 |
KPRX Number of Guru Trades
KPRX Volume of Guru Trades
Gurus Latest Trades with NAS:KPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KPRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kiora Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:KPRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers